Fermeate, an industrial biotechnology company using light to improve precision fermentation, has raised $2 million in a seed round led by Newfund Capital, with participation from SOSV, Ajinomoto Group Ventures, Ki Tua Fund, Heuristic Capital Partners, Momentum Capital, Plug & Play, Tesserakt Ventures, and Ag Startup Engine.
The funding will support the company’s mission to transform unit economics and enable cost parity for precision fermentation products.
Founded in 2024 by Kevin Xu and Saurabh Malani, both PhD alumni of the Avalos Lab at Princeton University, Fermeate addresses a persistent challenge in industrial fermentation: even highly optimized microbes can lose significant productivity over the course of a production run, reducing outputs and limiting efficiency. The company’s platform uses light to activate and deactivate gene expression in real time, enabling operators to influence microbial behavior during production with precise, dynamic control. AI is combined with the light-based approach to identify which genes to target and when, improving fermentation outputs by 60% to 300% based on results from existing industrial collaborations.
The core technology is designed to be plug-and-play with existing fermentation facilities, converting stainless-steel fermenters to optogenetically enabled systems at less than 5% of the cost of installing new tanks, with a typical payback period of under 11 months based on third-party techno-economic analyses. Fermeate has expanded its platform to support the most widely used industrial microbial hosts, including conventional and non-conventional yeast and bacterial species.
The company is currently engaged in partnerships with four global food and ingredient companies, demonstrating performance improvements within the first three months and up to 200% increases in protein production within six months.
KEY QUOTES:
“Until now, the fermentation industry has largely relied on scale to reduce costs. We take a different approach, unlocking more outputs from existing reactors with minimal capital investment and a typical payback period of under 11 months based on third-party TEAs.”
Kevin Xu, Co-Founder and CEO, Fermeate
“Every major industrial transformation is built on a foundational infrastructure layer, and the bio-economy will be no exception. What makes Fermeate stand out is that their optogenetic platform upgrades the world’s existing fermentation capacity rather than replacing it, precisely the kind of horizontal, enabling technology Newfund has consistently backed.”
Henri Deshays, General Partner, Newfund Capital
